In contrast, dietary fiber supplementation typically produces A1c reductions of 0.2-0.5% in systematic reviews, while berberine studies have shown variable reductions of approximately 0.5-1.0%, though many studies have methodological limitations
2017: University of Leeds researchers and Novo Nordisk report that semaglutide can be used to treat obesity
One observational study conducted in the UK showed a 0.51% reduction in HbA1c and a 5.8-kg reduction in weight, with one in six patients discontinuing insulin after 26 weeks of exenatide-insulin combination therapy
The key is working closely with your healthcare provider, listening to your body, and making adjustments as needed
When to Speak to Your GP or Prescriber Contact your GP promptly if you have no measurable improvement after reaching the target dose, experience persistent or severe side effects, or have obtained retatrutide outside a regulated clinical pathway